Abstract
Temporal Lobe Epilepsy (TLE) corresponds to 40% of all cases of epilepsy in adults, of which 70% are refractory to pharmacologic treatment. The successful identification of the epileptogenic lesion is an important goal in the treatment of patients with refractory epilepsy. Nevertheless, the histopathological basis for the MRI signal is still poorly understood and correlations between MRI …